Zhao, Jinlu*,; Li, Guodong*,; Ren, Yi; Zhang, Zhicheng; Chen, Hongsheng; Zhang, Haopeng; Zhao, Xingyu; Li, Wang; Jia, Yucheng; Guan, Xue; Liu, Ming
aDepartment of General Surgery, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, PR China
Received 21 November 2022 Revised form accepted 18 January 2023.
*These authors contributed equally to this work.
Correspondence to Ming Liu, Department of General Surgery, the Fourth Affiliated Hospital of Harbin Medical University, Harbin, 150001, P.R. China, Tel: +86 0451 85939302; e-mail: [email protected]
Anti-Cancer Drugs ():e001513, February 24, 2023. | DOI: 10.1097/CAD.0000000000001513